Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | NAMS | XNCR | ||
| Company | Recursion Pharmaceuticals Inc Cl A | Newamsterdam Pharma Company N.V. | Xencor Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.02 | 20.22 | 23.51 | ||
| High | 6.03 | 21.65 | 24.20 | ||
| Low | 5.62 | 19.89 | 23.50 | ||
| Last | 5.87 | 20.01 | 24.13 | ||
| Change | -0.17 | +0.10 | +0.41 | ||
| % Change | -2.81% | +0.50% | +1.73% | ||
| Volume | 10,211,457 | 846,420 | 405,117 | ||
| 20-Day Average Volume | 7,201,761 | 660,783 | 574,050 | ||
| Previous Close | 6.04 | 20.01 | 23.72 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.70 | 21.40 | 22.59 | ||
| 20-Day Raw Stochastic | 5.40% | 41.43% | 94.13% | ||
| 20-Day Relative Strength | 40.57% | 49.02% | 66.93% | ||
| Weighted Alpha | -38.47 | +33.05 | +12.03 | ||
| Today's Opinion | 88% Sell | 48% Buy | 88% Buy | ||
| Previous Opinion | 88% Sell | 48% Buy | 88% Buy | ||
| Last Month's Opinion | 96% Sell | 16% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.43% since 11/14/24 | -19.26% since 11/14/24 | +2.15% since 11/14/24 | ||
| Low | 5.62 on 11/21/24 | 19.59 on 11/20/24 | 22.60 on 11/15/24 | ||
| High | 6.92 on 11/15/24 | 25.32 on 11/18/24 | 24.20 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | -14.57% since 10/21/24 | +5.99% since 10/21/24 | +13.88% since 10/21/24 | ||
| Low | 5.62 on 11/21/24 | 16.51 on 11/01/24 | 20.70 on 10/22/24 | ||
| High | 8.49 on 11/11/24 | 25.32 on 11/18/24 | 24.20 on 11/21/24 | ||
| 3-Month | |||||
| %Chg | -24.21% since 08/21/24 | +23.91% since 08/21/24 | +37.96% since 08/21/24 | ||
| Low | 5.62 on 11/21/24 | 15.19 on 09/25/24 | 16.14 on 09/06/24 | ||
| High | 8.49 on 11/11/24 | 25.32 on 11/18/24 | 24.20 on 11/21/24 | ||
| 6-Month | |||||
| %Chg | -39.27% since 05/21/24 | +3.49% since 05/21/24 | +0.99% since 05/21/24 | ||
| Low | 5.62 on 11/21/24 | 15.19 on 09/25/24 | 15.31 on 08/07/24 | ||
| High | 9.99 on 06/18/24 | 25.32 on 11/18/24 | 25.41 on 06/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,731,312 | 1,848,644 | 1,659,973 | ||
| Shares Outstanding, K | 286,641 | 92,386 | 69,982 | ||
| Annual Sales | 44,580,000 | 14,090,000 | 168,340,000 | ||
| Annual Net Income | -328,070,000 | -176,940,000 | -126,090,000 | ||
| Last Quarter Sales | 26,080,000 | 29,110,000 | 10,710,000 | ||
| Last Quarter Net Income | -95,840,000 | -16,650,000 | -45,140,000 | ||
| 60-Month Beta | 0.81 | -0.01 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 11/06/24 | -0.18 on 11/06/24 | -0.71 on 11/06/24 | ||
| Latest Earnings Date | 11/06/24 | 11/06/24 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||